Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1

Cellular immunotherapy for soft tissue sarcomas

(2012) Steven Eric Finkelstein et al.   Immunotherapy

Epigenetic Modulation to Enable Antigen-specific T-cell Therapy of Colorectal Cancer

(2012) Jeffrey Chou et al.   JOURNAL OF IMMUNOTHERAPY

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma

(2012) D. K. Krishnadas et al.   PEDIATRICS

MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing

(2011) Lei Bao et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

(2011) Veerauo V Konkankit et al.   Journal of Translational Medicine

Wilms’ tumor 1-specific cytotoxic T lymphocytes can be expanded from adult donors and cord blood

(2011) Deepa K. Krishnadas et al.   LEUKEMIA RESEARCH

Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumors

(2010) Hiroki Yabe et al.   JOURNAL OF SURGICAL ONCOLOGY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epigenetic Mechanisms Regulate MHC and Antigen Processing Molecules in Human Embryonic and Induced Pluripotent Stem Cells

(2010) Beatriz Suárez-Álvarez et al.   PLoS One

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

(2010) W. Blum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities

(2009) Zhe Yu et al.   Expert Review of Anticancer Therapy

Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3

(2008) Y.-C. Chang et al.   BLOOD

Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules

(2008) Sara J. Adair et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY